Lehrstuhl für Haut- und Geschlechtskrankheiten

Editorial: Multiomics and multiparametric analyses to characterize myeloid cell subsets (2023) Vu Manh TP, Dalod M, Dudziak D Journal article Deepnapsi: Deep Learning for Nail Psoriasis Prediction (2023) Folle L, Fenzl P, Fagni F, Thies M, Christlein V, Meder C, Sticherling M, et al. Conference contribution Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate-to-severe atopic dermatitis: Analyses of TREATgermany registry data (2023) Birkner T, Siegels D, Heinrich L, Haufe E, Abraham S, Heratizadeh A, Harder I, et al. Journal article The future of affordable cancer immunotherapy (2023) Schaft N, Dörrie J, Schuler G, Schuler-Thurner B, Sallam H, Klein S, Eisenberg G, et al. Journal article, Review article Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections (2023) Schmitt C, Hoefsmit EP, Fangmeier T, Kramer N, Kabakci C, Vera González J, Versluis JM, et al. Journal article Author Correction: DeepNAPSI multi-reader nail psoriasis prediction using deep learning. (2023) Folle L, Fenzl P, Fagni F, Thies M, Christlein V, Meder C, Simon D, et al. Journal article, Erratum Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study. (2023) Tomsitz D, Ruf T, Heppt M, Staeger R, Ramelyte E, Dummer R, Garzarolli M, et al. Journal article Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial (2023) Koch E, Petzold A, Wessely A, Dippel E, Eckstein M, Gesierich A, Gutzmer R, et al. Journal article Case report: Bullous pemphigoid in HIV-1-positive patients: interplay or coincidence? A case series and review of the literature (2023) Foerster Y, Sollfrank L, Rechtien L, Harrer T, Berking C, Sticherling M Journal article Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials (2023) Sticherling M, Nikkels AF, Hamza AM, Kwong P, Szepietowski JC, El Sayed M, Ghislain PD, et al. Journal article